Prostate Cancer - Results from #28120

BJUI Mini Reviews - Effect of testosterone administration to men with prostate cancer is unpredictable: A word of caution and suggestions for a registry May 26, 2011

AUA 2011 - Educational needs of urologists on bone health in prostate cancer - Poster May 26, 2011

Brisk walking could improve prostate cancer outcomes May 26, 2011

Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts Gleason sum upgrading - Abstract May 25, 2011

Fracture risk in men with prostate cancer: A population-based study - Abstract May 25, 2011

Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: Comparison with other cancer preventive phytochemicals - Abstract May 25, 2011

Low-dose docetaxel in combination with dexamethasone for hormone-refractory prostate cancer - Abstract May 25, 2011

Quantification of prostate deformation due to needle insertion during TRUS-guided biopsy: Comparison of hand-held and mechanically stabilized systems - Abstract May 25, 2011

Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: Preliminary results - Abstract May 25, 2011

Current clinical trials in castrate-resistant prostate cancer - Abstract May 25, 2011

Prostate cancer radiotherapy in Austria : Overview on number of patients, intention to treat, and treatment techniques based on data from 2007 - Abstract May 25, 2011

Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy - Abstract May 25, 2011

BJUI Mini Reviews - Focal therapy in the management of localized prostate cancer May 25, 2011

The Association between pre-operative PSA and prostate cancer-specific mortality in patients with long-term follow-up after radical prostatectomy - Abstract May 24, 2011

Survival is associated with time to reach PSA nadir (DAN) and the ratio DAN/nadir value after androgen deprivation for prostate cancer - Abstract May 24, 2011

Prostate cancer risk variants are not associated with disease progression - Abstract May 24, 2011

Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥12)-core prostate biopsy - Abstract May 24, 2011

Treatment decision-making for localized prostate cancer: What younger men choose and why - Abstract May 24, 2011

Molecular chemotherapy and Chemotherapy: A new front against late stage hormone refractory prostate cancer - Abstract May 24, 2011

Combination therapy of recurrent prostate cancer with the proteasome inhibitor Bortezomib plus hormone blockade - Abstract May 24, 2011

Page 1407 of 1447